FDA Clears Insera’s CLEAR Aspiration System, Which Pulses Suction to Remove Peripheral Clots
Insera Therapeutics has FDA 510(k) clearance for a thrombectomy system that pulses suction instead of holding it steady. The clearance covers peripheral arteries and veins and rests on bench and animal testing. No clinical outcome data were submitted, and no US launch date has been announced.